Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer where drug resistance is a major treatment obstacle.
• Current research often examines single pathways or organelles, neglecting their coordinated roles in resistance.
• A comprehensive understanding of how subcellular structures interact to drive PDAC drug resistance is lacking.

Purpose of the Study:

• To review and synthesize current knowledge on subcellular structural homeostasis in the context of PDAC drug resistance.
• To examine the functional remodeling of key organelles (cell membrane, mitochondria, ER, ribosomes, lysosomes, exosomes, stress granules) in promoting resistance.
• To propose a new paradigm focusing on inter-organelle communication networks for therapeutic strategies.

Main Methods:

• Literature review synthesizing current research on organelle function and communication in PDAC.
• Analysis of how individual subcellular structures contribute to drug resistance.
• Examination of the integrated network of organelle communication, including mitochondria as signaling hubs and exosomes as intercellular messengers.

Main Results:

• Subcellular structures like mitochondria and exosomes play critical roles in a coordinated network that promotes PDAC drug resistance.
• Mitochondria act as central signaling hubs, integrating metabolic and stress signals.
• Exosomes facilitate intercellular communication, spreading drug resistance phenotypes.

Conclusions:

• Targeting individual organelles is often ineffective due to their interconnectedness.
• Disrupting inter-organelle communication networks holds significant therapeutic potential for PDAC.
• Future strategies should focus on combination approaches and non-invasive biomarkers to target these networks effectively.